Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Unraveling the impact of miR-21 on apoptosis regulation in glioblastoma
Mohammad Arshad Javed Shaikh, Abdulmalik Saleh Alfawaz Altamimi, Muhammad Afzal, et al.
Pathology - Research and Practice (2024) Vol. 254, pp. 155121-155121
Closed Access | Times Cited: 21

Showing 21 citing articles:

Exploring ncRNA-mediated regulation of EGFR signalling in glioblastoma: From mechanisms to therapeutics
Riya Thapa, Muhammad Afzal, Ahsas Goyal, et al.
Life Sciences (2024) Vol. 345, pp. 122613-122613
Closed Access | Times Cited: 24
Autophagy‐associated non‐coding RNAs: Unraveling their impact on Parkinson's disease pathogenesis
Md Sadique Hussain, Ehssan Moglad, Muhammad Afzal, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 5
Open Access | Times Cited: 18
ncRNAs and their impact on dopaminergic neurons: Autophagy pathways in Parkinson's disease
Riya Thapa, Ehssan Moglad, Muhammad Afzal, et al.
Ageing Research Reviews (2024) Vol. 98, pp. 102327-102327
Closed Access | Times Cited: 13
The Role of Sirtuin 1 in Ageing and Neurodegenerative Disease: A Molecular Perspective
Riya Thapa, Ehssan Moglad, Muhammad Afzal, et al.
Ageing Research Reviews (2024) Vol. 102, pp. 102545-102545
Closed Access | Times Cited: 9
Exploring Ubiquitin-Specific Proteases as Therapeutic Targets in Glioblastoma
Vijaya Paul Samuel, Ehssan Moglad, Muhammad Afzal, et al.
Pathology - Research and Practice (2024) Vol. 260, pp. 155443-155443
Closed Access | Times Cited: 8
Proteostasis disruption and senescence in Alzheimer’s disease pathways to neurodegeneration
Riya Thapa, Asif Ahmad Bhat, Moyad Shahwan, et al.
Brain Research (2024) Vol. 1845, pp. 149202-149202
Closed Access | Times Cited: 8
Non-Coding RNA: A Key Regulator in the Glutathione-GPX4 Pathway of Ferroptosis
Md Sadique Hussain, Gaurav Gupta, Moyad Shahwan, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 4, pp. 1222-1234
Open Access | Times Cited: 6
Therapeutic approaches targeting aging and cellular senescence in Huntington's disease
Asif Ahmad Bhat, Ehssan Moglad, Muhammad Afzal, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 10
Open Access | Times Cited: 6
piRNAs in leukemogenesis: Mechanisms, biomarkers, and therapeutic implications
Gaurav Gupta, Muhammad Afzal, Ahsas Goyal, et al.
Clinica Chimica Acta (2025), pp. 120220-120220
Closed Access
The Clinical Role of miRNAs in the Development and Treatment of Glioblastoma
Samantha Epistolio, Paolo Spina, Ismail Zaed, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2723-2723
Open Access
Mesenchymal-Stem-Cell-Based Therapy against Gliomas
Sisa M. Santillán-Guaján, Mehdi Hayat Shahi, Javier S. Castresana
Cells (2024) Vol. 13, Iss. 7, pp. 617-617
Open Access | Times Cited: 2
Tau proteins and senescent Cells: Targeting aging pathways in Alzheimer’s disease
Mahaveer Singh, Haider Ali, S. Renuka Jyothi, et al.
Brain Research (2024) Vol. 1844, pp. 149165-149165
Closed Access | Times Cited: 2
Targeting the autophagy-miRNA axis in prostate cancer: toward novel diagnostic and therapeutic strategies
Rahamat Unissa Syed, Maali D. Alshammari, Humera Banu, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 10, pp. 7421-7437
Closed Access | Times Cited: 1
Exploring ncRNAs in epilepsy: From oxidative stress regulation to therapy
Kumud Pant, Anchal Sharma, Soumya V. Menon, et al.
Brain Research (2024) Vol. 1841, pp. 149089-149089
Closed Access | Times Cited: 1
Non-Coding RNAs: Key Regulators of CDK and Wnt/β-catenin signaling in Cancer
Mohammad Arshad Javed Shaikh, M. Arockia Babu, Nehmat Ghaboura, et al.
Pathology - Research and Practice (2024) Vol. 263, pp. 155659-155659
Closed Access | Times Cited: 1
Decoding the Promise and Challenges of miRNA-Based Cancer Therapies: An Essential Update on miR-21, miR-34, and miR-155
Hongbo Qian, Mazaher Maghsoudloo, Parham Jabbarzadeh Kaboli, et al.
International Journal of Medical Sciences (2024) Vol. 21, Iss. 14, pp. 2781-2798
Open Access | Times Cited: 1
Role of miRNA-21 in cancer and its application in electrochemical bioanalysis
Masoud Negahdary
Bioanalysis (2024) Vol. 16, Iss. 19-20, pp. 997-1000
Closed Access
Therapeutic Approaches to Microglial Dysfunction in Alzheimer's Disease: Enhancing Phagocytosis and Metabolic Regulation
Waleed Hassan Almalki, Salem Salman Almujri
Pathology - Research and Practice (2024) Vol. 263, pp. 155614-155614
Closed Access
Non-Coding RNAs as Therapeutic Targets in Parkinson’s Disease: A Focus on Dopamine
Khalid Saad Alharbi
Pathology - Research and Practice (2024) Vol. 263, pp. 155641-155641
Closed Access
Therapeutic Potential of lncRNAs in Regulating Disulfidptosis for Cancer Treatment
Abida Abida, Abdulmalik S A Altamimi, Nehmat Ghaboura, et al.
Pathology - Research and Practice (2024) Vol. 263, pp. 155657-155657
Closed Access
Unlocking the Potential of Circulating miRNAs as Biomarkers in Glioblastoma
Sanika Suvarnapathaki, Antolin Serrano-Farias, Jonathan C. Dudley, et al.
Life (2024) Vol. 14, Iss. 10, pp. 1312-1312
Open Access
Page 1

Scroll to top